INVE-A Stock Analysis: Investor ser. | ST

Asset Management | ST, Sweden | Market Cap: 1.280.020m SEK | 12M Return: 30.9% | SE0015811955 | Charts, Fundamentals & Technical Analysis

Private Equity, Healthcare, Financial Holdings, Technology
Total Rating 63
Safety 71
Buy Signal -0.09
Environmental & Facilities Services
Sub-Industry Rotation: +9.9
Market Cap: 125B
Avg Turnover: 132M
Risk 3d forecast
Volatility25.4%
VaR 5th Pctl4.53%
VaR vs Median8.22%
Reward TTM
Sharpe Ratio1.54
Rel. Str. IBD79.1
Rel. Str. Peer Group77.1 pctl
Character TTM
Beta0.526
Beta Downside0.356
Hurst Exponent0.584
Choppyness41.6%
Drawdowns 3y
Max DD21.68%
CAGR/Max DD1.19
CAGR/Mean DD7.26
EPS (Earnings per Share) EPS (Earnings per Share) of INVE-A over the last years for every Quarter: "2021-09": 8.8033, "2021-12": 26.46, "2022-03": -22.5527, "2022-06": -21.38, "2022-09": 2.7334, "2022-12": 16.81, "2023-03": 10.7237, "2023-06": 14.8058, "2023-09": -3.621, "2023-12": 19.56, "2024-03": 21.87, "2024-06": 21.27, "2024-09": 4.1787, "2024-12": -10.3489, "2025-03": -0.9898, "2025-06": 14.78, "2025-09": 19.52, "2025-12": 18.07, "2026-03": 9.82, "2026-06": 38.26, "2026-09": 3.8881,
EPS CAGR: 10.52%
EPS Trend: 12.4%
Qual. Beats: 0
Revenue Revenue of INVE-A over the last years for every Quarter: 2021-09: 37657, 2021-12: 92153, 2022-03: -57362, 2022-06: -51916, 2022-09: 22447, 2022-12: 65661, 2023-03: 46457, 2023-06: 61241, 2023-09: 2442, 2023-12: 74711, 2024-03: 82210, 2024-06: 80866, 2024-09: 26774, 2024-12: -13955, 2025-03: 11905, 2025-06: 61579, 2025-09: 75355, 2025-12: 72988, 2026-03: 25923, 2026-06: 133926, 2026-09: 19900,
Rev. CAGR: 6.41%
Rev. Trend: 14.4%
Qual. Beats: 0

Warnings

Below Avwap Earnings

Tailwinds

No distinct edge detected

Seasonality 11.9 years of data, until 10/2026

Jan +0.7% 9
Feb +1.1% 14
Mar -0.9% 4
Apr +1.1% 4
May +0.8% 4
Jun -1.8% 28
Jul +1.4% 28
Aug -1.9% 14
Sep -1.7% 14
Oct +0.3% 0
Nov +0.2% 0
Dec -1.4% 21

How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, ≥40 worth a closer look and ≥60 is strong.

Description: INVE-A Investor ser.

Investor AB (publ), listed on the Stockholm Stock Exchange under ticker INVE-A, is a Swedish publicly traded investment company founded in 1916 and headquartered in Stockholm. Structured as a holding company under Swedish corporate law, it is classified under the GICS Industrials sector despite operating primarily as a private equity and investment vehicle. The firm is historically associated with the Wallenberg family, one of Swedens most prominent industrial dynasties, and ranks among the largest listed investment companies in the Nordic region.

The firm specializes in mature, middle-market buyouts and growth capital investments, with core investments spanning healthcare, financial services, IT and fintech, life sciences, materials science, AI, and quantum technology. It targets leading minority positions in listed companies and seeks global deployment opportunities, with operating investments focused on medium-sized to large companies headquartered in Northern Europe.

Investor AB typically deploys between $200 million and $700 million per transaction, considering both majority and minority stakes in listed and unlisted companies. It generally holds investments for a 3-7 year horizon, seeks board representation in portfolio companies, and distinguishes between long-term operating investments and shorter-horizon financial holdings.

Headlines to Watch Out For
  • Atlas Copco and ABB earnings lift fair value of listed holdings
  • Dividend payout and buybacks support total shareholder returns
  • Unlisted investments gain traction in healthcare and industrial tech
Piotroski VR-10 (Strict) 6.5
Net Income: 215b TTM > 0 and > 6% of Revenue
FCF/TA: 0.02 > 0.02 and ΔFCF/TA 0.07 > 1.0
NWC/Revenue: 6.53% < 20% (prev 19.74%; Δ -13.21% < -1%)
CFO/TA 0.02 > 3% & CFO 26.5b > Net Income 215b
Net Debt (111b) to EBITDA (220b): 0.50 < 3
Current Ratio: 1.84 > 1.5 & < 3
Outstanding Shares: last quarter (3.06b) vs 12m ago -0.05% < -2%
Gross Margin: 91.85% > 18% (prev 88.36%; Δ 3.49% > 0.5%)
Asset Turnover: 21.81% > 50% (prev 12.81%; Δ 9.00% > 0%)
Interest Coverage Ratio: 38.02 > 6 (EBIT TTM 220b / Interest Expense TTM 5.78b)
Altman Z'' 10.00
A: 0.01 (Total Current Assets 36.2b - Total Current Liabilities 19.7b) / Total Assets 1265b
B: 0.73 (Retained Earnings 925b / Total Assets 1265b)
C: 0.19 (EBIT TTM 220b / Avg Total Assets 1159b)
D: 6.64 (Book Value of Equity 1099b / Total Liabilities 165b)
Altman-Z'' = 10.72 = AAA
Beneish M -2.52
DSRI: 0.86 (Receivables 19.6b/12.1b, Revenue 253b/135b)
GMI: 0.96 (GM 88.36% / 91.85%)
AQI: 1.02 (AQ_t 0.95 / AQ_t-1 0.94)
SGI: 1.87 (Revenue 253b / 135b)
TATA: 0.15 (NI 215b - CFO 26.5b) / TA 1265b)
Beneish M = -2.52 (Cap -4..+1) = A
What is the price of INVE-A shares?

As of November 22, 2026, the stock is trading at SEK 401.40 with a total of 378,889 shares traded. Over the past week, the price has changed by -6.13%, over one month by -0.88%, over three months by -0.61% and over the past year by +30.89%.

Current recommended Stop Loss: 393.30 (which is 2% or 1.4 ATR below the current price).

Is INVE-A a buy, sell or hold?

Investor ser. has no consensus analysts rating.

Investor ser. (INVE-A) - Fundamental Data Overview as of 18 November 2026
Market Cap USD = 125b (1280b SEK * 0.0978 SEK.USD)
P/E Trailing = 5.9652
P/E Forward = 3.6711
P/S = 4.5328
P/B = 1.192
P/EG = 4.9117
Revenue TTM = 253b SEK
EBIT TTM = 220b SEK
EBITDA TTM = 220b SEK
Long Term Debt = 111b SEK (from longTermDebt, last fiscal year)
Short Term Debt = 1.43b SEK (from shortTermDebt, last quarter)
Debt = 127b SEK (from shortLongTermDebtTotal, last quarter) + Leases 128.0m
Net Debt = 111b SEK (calculated: Debt 127b - CCE 16.7b)
Enterprise Value = 1391b SEK (1280b + Debt 127b - CCE 16.7b)
Interest Coverage Ratio = 38.02 (Ebit TTM 220b / Interest Expense TTM 5.78b)
EV/FCF = 60.30x (Enterprise Value 1391b / FCF TTM 23.1b)
FCF Yield = 1.66% (FCF TTM 23.1b / Enterprise Value 1391b)
FCF Margin = 9.13% (FCF TTM 23.1b / Revenue TTM 253b)
Net Margin = 84.96% (Net Income TTM 215b / Revenue TTM 253b)
Gross Margin = 91.85% ((Revenue TTM 253b - Cost of Revenue TTM 20.6b) / Revenue TTM)
Gross Margin QoQ = 53.31% (prev none%)
Tobins Q-Ratio = 1.10 (Enterprise Value 1391b / Total Assets 1265b)
Interest Expense / Debt = 4.54% (Interest Expense 5.78b / Debt 127b)
Taxrate = 0.75% (1.62b / 216b)
NOPAT = 218b (EBIT 220b * (1 - 0.75%))
Current Ratio = 1.84 (Total Current Assets 36.2b / Total Current Liabilities 19.7b)
Debt / Equity = 0.12 (Debt 127b / totalStockholderEquity, last quarter 1099b)
Debt / EBITDA = 0.50 (Net Debt 111b / EBITDA 220b)
Debt / FCF = 4.80 (Net Debt 111b / FCF TTM 23.1b)
Total Stockholder Equity = 1031b (last 4 quarters mean from totalStockholderEquity)
RoA = 18.53% (Net Income 215b / Total Assets 1265b)
RoE = 20.83% (Net Income TTM 215b / Total Stockholder Equity 1031b)
RoCE = 19.25% (EBIT 220b / Capital Employed (Equity 1031b + L.T.Debt 111b))
RoIC = 17.42% (NOPAT 218b / Invested Capital 1252b)
WACC = 7.15% (E(1280b)/V(1407b) * Re(7.41%) + D(127b)/V(1407b) * Rd(4.54%) * (1-Tc(0.01)))
Discount Rate = 7.41% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 44.56 | Cagr: -0.03%
[DCF] Terminal Value 77.97% ; FCFF base≈21.2b ; Y1≈24.3b ; Y5≈35.8b
[DCF] Fair Price = 343.6 (EV 539b - Net Debt 111b = Equity 428b / Shares 1.25b; r=8.35% [WACC [floored]]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: 12.42 | EPS CAGR: 10.52% | SUE: N/A | # QB: 0
Revenue Correlation: 14.39 | Revenue CAGR: 6.41% | SUE: N/A | # QB: 0
EPS current Year (2026-12-31): EPS=34.78 | Chg30d=N/A | Revisions=+0% | GrowthEPS=+0.0% | GrowthRev=+5.1%
EPS next Year (2027-12-31): EPS=0.00 | Chg30d=N/A | Revisions=N/A | GrowthEPS=+0.0% | GrowthRev=+0.5%